Blonder Tongue Laboratories Inc
Blonder Tongue Laboratories, Inc., a technology-development and manufacturing company, provides television (TV) signal encoding, transcoding, digital transport, and broadband product solutions in the United States. It offers encoders/transcoders, such as 4K/ultra-high definition, high definition and standard definition, MPEG-2, MPEG-4/H.264, and HEVC/H.265 capable encoders and transcoders; and QP… Read more
Blonder Tongue Laboratories Inc (BDRL) - Net Assets
Latest net assets as of March 2025: $-2.04 Million USD
Based on the latest financial reports, Blonder Tongue Laboratories Inc (BDRL) has net assets worth $-2.04 Million USD as of March 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($9.27 Million) and total liabilities ($11.31 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-2.04 Million |
| % of Total Assets | -22.04% |
| Annual Growth Rate | N/A |
| 5-Year Change | -239.77% |
| 10-Year Change | -123.46% |
| Growth Volatility | 48.71 |
Blonder Tongue Laboratories Inc - Net Assets Trend (1995–2024)
This chart illustrates how Blonder Tongue Laboratories Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Blonder Tongue Laboratories Inc (1995–2024)
The table below shows the annual net assets of Blonder Tongue Laboratories Inc from 1995 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-1.73 Million | -229.96% |
| 2023-12-31 | $-524.00K | -148.79% |
| 2022-12-31 | $1.07 Million | -67.31% |
| 2021-12-31 | $3.29 Million | +165.56% |
| 2020-12-31 | $1.24 Million | -83.20% |
| 2019-12-31 | $7.36 Million | +2.73% |
| 2018-12-31 | $7.17 Million | -3.32% |
| 2017-12-31 | $7.41 Million | +13.45% |
| 2016-12-31 | $6.53 Million | -11.33% |
| 2015-12-31 | $7.37 Million | -46.36% |
| 2014-12-31 | $13.74 Million | -8.58% |
| 2013-12-31 | $15.03 Million | -9.61% |
| 2012-12-31 | $16.62 Million | -21.59% |
| 2011-12-31 | $21.20 Million | -3.81% |
| 2010-12-31 | $22.04 Million | +9.37% |
| 2009-12-31 | $20.16 Million | +3.70% |
| 2008-12-31 | $19.44 Million | -6.00% |
| 2007-12-31 | $20.68 Million | +2.20% |
| 2006-12-31 | $20.23 Million | -5.89% |
| 2005-12-31 | $21.50 Million | -20.15% |
| 2004-12-31 | $26.92 Million | -15.71% |
| 2003-12-31 | $31.94 Million | -3.99% |
| 2002-12-31 | $33.27 Million | -16.75% |
| 2001-12-31 | $39.96 Million | +2.22% |
| 2000-12-31 | $39.10 Million | +10.92% |
| 1999-12-31 | $35.25 Million | -12.97% |
| 1998-12-31 | $40.50 Million | +27.36% |
| 1997-12-31 | $31.80 Million | +24.22% |
| 1996-12-31 | $25.60 Million | +29.95% |
| 1995-12-31 | $19.70 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Blonder Tongue Laboratories Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 16897.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $14.00K | % |
| Other Comprehensive Income | $-827.00K | % |
| Other Components | $32.68 Million | % |
| Total Equity | $-1.73 Million | 100.00% |
Blonder Tongue Laboratories Inc Competitors by Market Cap
The table below lists competitors of Blonder Tongue Laboratories Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ECKERT & ZIEGLER
BE:EUZ
|
$144.73K |
|
M'BISHI UFJ FINL
HM:MFZ
|
$144.83K |
|
Companhia Estadual de Distribuição de Energia Elétrica
SA:CEED3
|
$144.84K |
|
Clave Indices De Precos Fundo De Investimento Imobiliario
SA:CLIN11
|
$144.86K |
|
Nykredit Invest Ansv Kreditobl
CO:NYIAKO
|
$144.67K |
|
AXON PARTNERS GRP EO -10
F:XE1
|
$144.64K |
|
RACL Geartech Limited
NSE:RACLGEAR
|
$144.64K |
|
MINEBEA (MEA.SG)
STU:MEA
|
$144.60K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Blonder Tongue Laboratories Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -524,000 to -1,729,000, a change of -1,205,000.
- Net loss of 1,248,000 reduced equity.
- Other comprehensive income decreased equity by 11,000.
- Other factors increased equity by 54,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.25 Million | -72.18% |
| Other Comprehensive Income | $-11.00K | -0.64% |
| Other Changes | $54.00K | +3.12% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Blonder Tongue Laboratories Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1995-12-31 | $2.29 | $0.05 | x |
| 1996-12-31 | $3.03 | $0.05 | x |
| 1997-12-31 | $3.80 | $0.05 | x |
| 1998-12-31 | $4.78 | $0.05 | x |
| 1999-12-31 | $4.43 | $0.05 | x |
| 2000-12-31 | $5.12 | $0.05 | x |
| 2001-12-31 | $5.23 | $0.05 | x |
| 2002-12-31 | $4.37 | $0.05 | x |
| 2003-12-31 | $4.17 | $0.05 | x |
| 2004-12-31 | $3.35 | $0.05 | x |
| 2005-12-31 | $2.68 | $0.05 | x |
| 2006-12-31 | $2.66 | $0.05 | x |
| 2007-12-31 | $3.32 | $0.05 | x |
| 2008-12-31 | $3.12 | $0.05 | x |
| 2009-12-31 | $3.25 | $0.05 | x |
| 2010-12-31 | $3.51 | $0.05 | x |
| 2011-12-31 | $3.41 | $0.05 | x |
| 2012-12-31 | $2.67 | $0.05 | x |
| 2013-12-31 | $2.42 | $0.05 | x |
| 2014-12-31 | $2.21 | $0.05 | x |
| 2015-12-31 | $1.14 | $0.05 | x |
| 2016-12-31 | $0.88 | $0.05 | x |
| 2017-12-31 | $0.91 | $0.05 | x |
| 2018-12-31 | $0.81 | $0.05 | x |
| 2019-12-31 | $0.77 | $0.05 | x |
| 2020-12-31 | $0.12 | $0.05 | x |
| 2021-12-31 | $0.21 | $0.05 | x |
| 2022-12-31 | $0.08 | $0.05 | x |
| 2023-12-31 | $-0.04 | $0.05 | x |
| 2024-12-31 | $-0.12 | $0.05 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Blonder Tongue Laboratories Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -11.18%
- • Asset Turnover: 1.18x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-8.97%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1995 | 27.92% | 10.58% | 1.64x | 1.61x | $3.53 Million |
| 1996 | 15.23% | 7.98% | 1.35x | 1.41x | $1.34 Million |
| 1997 | 20.13% | 10.31% | 1.47x | 1.33x | $3.22 Million |
| 1998 | 17.53% | 10.03% | 1.02x | 1.72x | $3.05 Million |
| 1999 | 0.17% | 0.10% | 0.86x | 1.87x | $-3.47 Million |
| 2000 | 9.15% | 5.09% | 1.12x | 1.61x | $-333.60K |
| 2001 | 3.05% | 2.27% | 0.83x | 1.61x | $-2.78 Million |
| 2002 | -19.41% | -13.75% | 0.90x | 1.56x | $-9.78 Million |
| 2003 | -8.61% | -7.76% | 0.74x | 1.50x | $-5.94 Million |
| 2004 | -11.60% | -7.96% | 1.03x | 1.42x | $-5.81 Million |
| 2005 | -25.58% | -15.08% | 1.11x | 1.53x | $-7.65 Million |
| 2006 | 1.69% | 0.96% | 1.31x | 1.35x | $-1.68 Million |
| 2007 | -2.71% | -1.69% | 1.28x | 1.25x | $-2.63 Million |
| 2008 | -2.11% | -1.16% | 1.31x | 1.39x | $-2.35 Million |
| 2009 | 0.37% | 0.26% | 1.15x | 1.25x | $-1.94 Million |
| 2010 | 8.10% | 5.85% | 1.15x | 1.21x | $-419.30K |
| 2011 | -1.94% | -1.54% | 1.03x | 1.22x | $-2.53 Million |
| 2012 | -31.02% | -16.83% | 1.17x | 1.58x | $-6.82 Million |
| 2013 | -18.78% | -10.13% | 1.23x | 1.51x | $-4.32 Million |
| 2014 | -6.57% | -3.10% | 1.37x | 1.55x | $-2.28 Million |
| 2015 | -91.88% | -32.33% | 1.29x | 2.20x | $-7.51 Million |
| 2016 | -18.29% | -5.31% | 1.50x | 2.30x | $-1.85 Million |
| 2017 | -5.18% | -1.65% | 1.53x | 2.05x | $-1.13 Million |
| 2018 | -18.68% | -6.17% | 1.39x | 2.18x | $-2.06 Million |
| 2019 | -10.08% | -3.74% | 1.08x | 2.49x | $-1.48 Million |
| 2020 | 242.76% | 18.33% | 1.47x | 9.00x | $2.88 Million |
| 2021 | 2.56% | 0.53% | 1.32x | 3.63x | $-244.50K |
| 2022 | -345.34% | -20.47% | 1.21x | 13.97x | $-3.82 Million |
| 2023 | 0.00% | -16.02% | 1.16x | 0.00x | $-2.06 Million |
| 2024 | 0.00% | -11.18% | 1.18x | 0.00x | $-1.08 Million |
Industry Comparison
This section compares Blonder Tongue Laboratories Inc's net assets metrics with peer companies in the Communication Equipment industry.
Industry Context
- Industry: Communication Equipment
- Average net assets among peers: $1,490,345,014
- Average return on equity (ROE) among peers: -191.93%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Blonder Tongue Laboratories Inc (BDRL) | $-2.04 Million | 27.92% | N/A | $144.72K |
| AAC Technologies Holdings Inc (AACAY) | $14.21 Billion | 28.32% | 0.71x | $4.55 Billion |
| Applied Opt (AAOI) | $115.01 Million | 3.72% | 0.60x | $2.97 Billion |
| Ability Inc (ABILF) | $5.00 Million | -5.60% | 13.35x | $544.32 |
| ADTRAN Inc (ADTN) | $378.43 Million | 20.17% | 0.27x | $785.61 Million |
| ADVA Optical Networking SE (ADVOF) | $176.06 Million | -16.73% | 0.17x | $243.68 Million |
| Airgain Inc (AIRG) | $46.22 Million | 2.47% | 0.22x | $44.70 Million |
| Aerkomm Inc (AKOM) | $24.19 Million | -98.53% | 2.63x | $805.19K |
| Akoustis Technologies, Inc. (AKTSQ) | $-57.09 Million | 0.00% | 0.00x | $135.67K |
| Amplitech Group Inc (AMPG) | $440.28K | -233.03% | 5.39x | $50.17 Million |
| Actelis Networks Inc. (ASNS) | $388.00K | -1620.10% | 27.93x | $465.34K |